Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab vs placebo in adults with Netherton syndrome
2019-001220-35Phase 2Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Apr 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Netherton syndrome (NS) comparing Dupilumab with Placebo (2 arms). Primary endpoint: Change in NASA score at week 16 vs baseline. Started Apr 2019; status: completed.
02
Drugs
03
Conditions
Netherton syndrome (NS)
Beyond the preview
Go deeper on 2019-001220-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001220-35.